Lincoln Pharma gets Gujarat food and drug controller gesture to make HCQ tablets Kumar Jeetendra | April 27, 2020 Lincoln Pharmaceuticals hit an upper circuit breaking point of 5% at Rs 152.70 after the organization said it got endorsement to fabricate Hydroxychloroquine and Hydroxychloroquine Sulfate tablets to battle Covid-19. Lincoln Pharmaceuticals reported during exchanging hours today, 27 April 2020, that it has gotten endorsement to make Hydroxychloroquine (HCQ) among other basic medications to battle …
